THE BEAUTY HEALTH COMPANY

(SKIN)
  Report
Delayed Nasdaq  -  05/20 04:00:00 pm EDT
11.98 USD   -0.33%
05/19The Beauty Health Company to Present at Spring 2022 Investor Conferences
BU
05/18BeautyHealth's HydraFacial Announces Second Annual GLOWvolution Tour
BU
05/12DA Davidson Lowers The Beauty Health Company's Price Target to $24 From $35, Maintains Buy Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Consumer Discretionary Stocks Leading Monday Markets Lower

01/10/2022 | 01:36pm EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
FIVE BELOW, INC. -4.74% 117.54 Delayed Quote.-43.19%
TAKE-TWO INTERACTIVE SOFTWARE, INC. -3.04% 116.12 Delayed Quote.-32.61%
THE BEAUTY HEALTH COMPANY -0.33% 11.98 Delayed Quote.-50.41%
ZYNGA INC. -2.04% 8.18 Delayed Quote.27.81%
All news about THE BEAUTY HEALTH COMPANY
05/19The Beauty Health Company to Present at Spring 2022 Investor Conferences
BU
05/18BeautyHealth's HydraFacial Announces Second Annual GLOWvolution Tour
BU
05/12DA Davidson Lowers The Beauty Health Company's Price Target to $24 From $35, Maintains ..
MT
05/11US Stocks Fall After Higher-Than-Anticipated Inflation Rate
MT
05/11US Stocks Close Lower Amid Concerns Over Higher-Than-Anticipated April Inflation Print
MT
05/11SECTOR UPDATE : Consumer Stocks Continue to Sag in Late Trade
MT
05/11SECTOR UPDATE : Consumer
MT
05/11The Beauty Health Company Widens Q1 Loss as Revenue Rises; Increases 2022 Revenue Guida..
MT
05/11Goldman Sachs Adjusts Price Target for The Beauty Health Company to $25 From $29, Maint..
MT
05/11Piper Sandler Lowers The Beauty Health Company's Price Target to $24 From $26, Maintain..
MT
More news
Analyst Recommendations on THE BEAUTY HEALTH COMPANY
More recommendations
Financials (USD)
Sales 2022 337 M - -
Net income 2022 33,0 M - -
Net cash 2022 413 M - -
P/E ratio 2022 56,2x
Yield 2022 -
Capitalization 1 805 M 1 805 M -
EV / Sales 2022 4,13x
EV / Sales 2023 3,25x
Nbr of Employees 704
Free-Float 91,7%
Chart THE BEAUTY HEALTH COMPANY
Duration : Period :
The Beauty Health Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends THE BEAUTY HEALTH COMPANY
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Last Close Price 11,98 $
Average target price 22,78 $
Spread / Average Target 90,1%
EPS Revisions
Managers and Directors
Andrew Stanleick President, Chief Executive Officer & Director
Liyuan Woo Chief Financial Officer & Executive Vice President
Brenton L. Saunders Executive Chairman
Michael D. Capellas Independent Director
Julius Few Independent Director
Sector and Competitors
1st jan.Capi. (M$)
THE BEAUTY HEALTH COMPANY-50.41%1 805
L'ORÉAL-26.18%175 249
KAO CORPORATION-16.65%18 669
SHISEIDO COMPANY, LIMITED-19.50%16 198
YUNNAN BOTANEE BIO-TECHNOLOGY GROUP CO.LTD-7.30%10 837
AMOREPACIFIC CORPORATION-8.08%7 618